Responsible Investments Report 2024

ESG highlights

8

Active in the global RI community

Contributing actively to industry-wide responsible investment discussions and promoting best practices across the investment community are key components of our ESG work.

Collaborative Engagements We recognize the value of collaborative engagements in our active ownership strategy, as they allow us to share industry perspectives and expand our impact. In 2024, we participated in 672 collaborative engagements, leading 103 of these. Key collaborations focused on Climate Action 100+, Nature Action 100+, Corporate Human Rights Benchmark, Oil & Gas Methane Partnership 2.0 (OGMP), and Pharma Industry Engagement. Complementing these efforts, we also individu - ally engaged with 721 companies during the same period, demonstrating our commitment to both collective and direct approaches in promoting sustainable practices. We continued our Methane Engagement campaign, which was awarded the "Recognition for Action – Climate" award at the Principles for Responsible Investment (PRI) Awards cer- emony in Toronto, Canada. We have also signed the Investor Action on AMR (IAAMR) Public Investor Statement, together with other institutional investors, to stress our concerns regarding antimicrobial resistance (AMR) as a systemic risk to investment portfolios, economic stability and society. Through these collaborative initiatives, we continue to leverage our joint influence to driving positive change, promoting sustain- able practices, and creating long-term value for our clients and stakeholders. Academic Collaborations Eric Pedersen, our Head of Responsible Investments, holds academic positions at Copenhagen Business School and Bos- ton University. In 2024, the Responsible Investment team col- laborated with students on research projects, delivered guest lectures, and supported the development of research papers on regulatory and transition dynamics. As an example, the team has contributed to the IGCC report 16 on methane emis- sions from fossil fuel operations, following their work with the Oil & Gas Methane Partnership 2.0.

Participating in investor initiatives is a way for us to exchange knowledge, shape the sustainable finance industry and to benchmark and develop our own ESG approach and frame- work. During 2024, we were active in 31 investor initiatives across a broad range of ESG topics. We were also active in sev- eral Sustainable Investment Forums (SIFs) throughout Europe and participated in numerous engagements in collaboration with other investors. While these initiatives and collaborative actions are an extremely important part of our work, we recognize that our role and responsibility in the RI community extend beyond these initiatives. We aim to engage with our stakeholders, to educate and learn. We do this by participating in events and discussions, contributing to publications, engaging with our clients and fostering academic collaborations. Industry Committees Representation We continued our active engagement in key industry initia- tives committees throughout 2024. As founding members of the ISSB Investor Advisory Group (formerly SASB's Investor Advisory Group), we helped shape global sustainability dis- closure standards, with our Head of Responsible Investments, Eric Pedersen, representing NAM. We lead company disclosure engagements and demonstrate ISSB standards' investor appli- cations across scenarios. Additionally, we have been supporters of TCFD (now closed), whose reporting requirements were incorporated into the ISSB standard, which provides a foun- dation for climate-related financial disclosures, encouraging companies to report on climate risks and opportunities most relevant to their business activities. Our Head of Climate and Nature Team, Cecilia Fryklöf, partici- pated on the steering committee of the Investor Initiative on Hazardous Chemicals (IIHC), addressing environmental and financial risks associated with chemical use. Since 2018 we have held a unique position as the sole asset manager on the Advisory Board of the Pharmaceutical Supply Chain Initiative, promoting responsible practices in the industry.

16) IGCC Report: Momentum: Addressing methane emissions from fossil fuel operations.

Made with FlippingBook. PDF to flipbook with ease